Blockchain Registration Transaction Record

Carmed Pharmaceuticals Expands U.S. Reach with OneLavi Wellness Launch

Carmed Pharmaceuticals launches carvacrol-based wellness formulations on OneLavi marketplace, expanding U.S. distribution with research-driven botanical products for immune and cellular health support.

This expansion matters because it brings scientifically-formulated, standardized botanical products to American consumers through a curated platform that prioritizes quality and transparency. As consumers increasingly seek evidence-based wellness solutions beyond traditional supplements, Carmed's research-driven approach combining traditional botanical knowledge with modern pharmaceutical methodology offers a new standard in the wellness industry. The availability of these formulations, particularly those that are gluten-free, non-GMO, and halal-certified, addresses growing demand for specialized health products that accommodate diverse dietary and lifestyle needs. Furthermore, the company's commitment to academic research and GMP manufacturing provides consumers with greater confidence in product quality and consistency, potentially raising industry standards for botanical formulations in the competitive U.S. wellness market.